Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy

Stephen G. Schwartz, Harry W. Flynn, Wen Hsiang Lee, Xue Wang

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


Retinal detachment (RD) with proliferative vitreoretinopathy (PVR) often requires surgery to restore normal anatomy and to stabilize or were not specified. Of the 94 participants, four died, 26 had recurrent retinal detachment, 22 developed glaucoma, four developed a cataract, and two had capsular fibrosis.All three trials employed adequate methods for random sequence generation and allocation concealment. None of the trials employed masking of participants and surgeons, and only the third trial masked outcome assessors. The first trial had a large portion of participants excluded from the final analyses, while the other two trials were at low risk of attrition bias. All trials appear to be free of reporting bias. The first two trials were funded by the National Eye Institute, and the third trial was funded by the German Research Foundation. The use of either perfluropropane or standard silicone oil appears reasonable for most patients with RD associated with PVR. Because there do not appear to be any major differences in outcomes between the two agents, the choice of a tamponade agent should be individualized for each patient. Heavy silicone oil, which is not available for routine clinical use in the USA, has not demonstrated evidence of superiority over standard silicone oil.

Original languageEnglish (US)
Article numberCD006126
JournalCochrane Database of Systematic Reviews
Issue number2
StatePublished - Feb 14 2014

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy'. Together they form a unique fingerprint.

Cite this